In a report released yesterday, Dane Leone from BTIG maintained a Sell rating on Johnson & Johnson (NYSE: JNJ), with a price target of $110. The company’s shares closed yesterday at $123.72, close to its 52-week low of $121.28.
According to TipRanks.com, Leone is a 5-star analyst with an average return of 21.1% and a 71.7% success rate. Leone covers the Healthcare sector, focusing on stocks such as Voyager Therapeutics Inc, Vertex Pharmaceuticals, and Blueprint Medicines.
Johnson & Johnson has an analyst consensus of Moderate Buy, with a price target consensus of $144.78.
See today’s analyst top recommended stocks >>
The company has a one-year high of $148.32 and a one-year low of $121.28. Currently, Johnson & Johnson has an average volume of 6.58M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
